GlaxoSmithKline | Pre Utilidad Fiscal



Pre Tax Profit Cambio Fecha
AbbVie USD 1.66B 3.15B 2025-03
Alcon AG USD 414M 65M 2025-03
Almirall EUR 35.8M 37.9M 2025-03
Amgen USD 1.97B 1.41B 2025-03
argenx SE USD 286.9M 84.54M 2025-06
AstraZeneca USD 3.13B 275M 2025-06
Bayer EUR 1.83B 2.31B 2025-03
Biogen USD 744M 432.8M 2025-06
Bristol-Myers Squibb USD 1.77B 1.2B 2025-06
Eli Lilly USD 3.46B 2.08B 2025-03
Fresenius EUR 611M 210M 2025-03
Fresenius Medical Care EUR 250.65M 70.73M 2025-03
Galapagos EUR -156367000 175.4M 2025-03
Genmab DKK 244M 3.36B 2025-03
Gilead Sciences USD 2.96B 112M 2024-12
GlaxoSmithKline GBP 1.89B 221M 2025-06
Glaxosmithkline USD 1.66B 1.78B 2024-12
GRIFOLS EUR 190.51M 20.03M 2025-06
Hikma Pharmaceutical USD 144M 144M 2024-06
Lonza CHF 624M 197M 2024-12
Merck EUR 956M 147M 2025-03
Merck USD 6.77B 864M 2025-06
Novartis USD 4.53B 124M 2025-06
Novo Nordisk 37.03B 2.65B 2025-03
Orion EUR 103.4M 26.6M 2025-06
Pfizer USD 2.78B 1.65B 2025-03
Philips EUR 337M 28M 2025-06
Recordati EUR 119.49M 45.37M 2025-06
Regeneron Pharmaceuticals USD 1.52B 613.7M 2025-06
Roche Holding CHF 1.78B 2.33B 2024-12
Sanofi EUR 1.42B 734M 2025-06
Smith & Nephew 399M 165M 2024-06
UCB EUR 1.22B 781M 2024-12


GlaxoSmithKline Pre Utilidad Fiscal - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Aug 2025.